Results

Total Results: 1,524 records

Showing results for "drugs".

121. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
     July 09, 2013 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The search is on for ways to definitively diagnose AD and for drugs, biologics, and alternative or … The Horizon Scanning System is tracking several drugs in late-phase development. … Peripheral and Central Nervous System Drugs Advisory Committee.

122. Atrial-Fibrillation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_executive.pdf
     June 01, 2013 - to be similar enough to be grouped together and all beta blocker drugs to be similar enough to be … • Although based on limited studies and use of different drugs for pretreatment, current evidence … Procedural therapies: • Transcatheter PVI versus antiarrhythmic drugs – Based on eight RCTs (five … For KQ 3, our findings underscore the need for additional studies to compare rate-control drugs with … of the comparative safety and effectiveness of these different drugs and procedures.

123. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
     March 09, 2010 - Center Systematic Review Protocol Project Title: The Effectiveness of Disease-Modifying Antirheumatic Drugs … Therapy with the so-called disease-modifying anti-rheumatic drugs (DMARDs) has become an increasingly … These drugs, which operate through a number of different mechanisms (see Table 2), share the common … effect of limiting radiologic progression of disease.4 Although these drugs can dramatically improve … There are many unanswered questions about the safety and effectiveness of these drugs, especially for

124. Noninvasive Treatments for Low Back Pain: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
     November 01, 2016 - . �� Pharmacological interventions: Nonsteroidal anti- inflammatory drugs (NSAIDs) may be effective … Furthermore, several of the trials evaluating antidepressants were funded by the manufacturers of the drugs … Drugs FDA Black Box Warning Opioids (immediate-release) ��Misuse, abuse, addiction, overdose, and … death Nonsteroidal anti-inflammatory drugs ��Cardiovascular thrombotic events, including myocardial … can be fatal Antidepressants �� Suicidal thoughts and behaviors Table 5: FDA Black Box Warnings for Drugs

125. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - dossiers from five pharmaceutical companies (AstraZeneca, Eli Lilly, GlaxoSmithKline, Warner Chilcott Pharmaceuticals … • Mirtazapine led to higher weight gains than comparator drugs. … The incidence was 8 percent (95% CI, 3 to 11 percent) higher than with comparator drugs. … The strength of evidence that trazodone leads to higher rates of somnolence than comparator drugs is … Evidence of high and moderate strength supports some differences among individual drugs with respect

126. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
     September 01, 2011 - This review did not evaluate pharmacokinetics of the drugs. … into the text of the report for methotrexate or the other drugs. … I would also indicate the drugs that you are referring to. … So a moderate SoE for symptoms only applies to a few drugs not the entire class. … Specific drugs are described in the text.

127. Drug Reactions | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/drug-reactions

128. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

129. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1506.pdf
     December 01, 2015 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

130. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

131. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

132. Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel - Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
     November 01, 2017 - characteristics (e.g., age, type and dose of opioid involved in overdose, or involvement of other drugs … in overdose, response to naloxone (e.g., based on Glasgow Coma Scale score), other substances and drugs … Amphastar Pharmaceuticals. FDA Advisory Committee Briefing Materials. … Amphastar Pharmaceuticals. … opioide overdose 2016. http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs

133. Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/juvenile-arthritis-dmards/research

134. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Autism treatments and drugs. [internet].

135. Tinnitus Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_executive.pdf
     August 01, 2013 - Five articles12-16 investigated antidepressant drugs versus placebo. … These drugs included sertraline,12,13 paroxetine,14 trazodone,15 and nortriptyline.16 Dosage levels … The neurotransmitter drugs were gabapentin,17 baclofen,18 alprazolam,19 and acamprosate.20,21 Three … studies investigated other drugs, including methylprednisolone versus placebo,22 vardenafil versus … , food supplements, and other drugs Evidence suggests that neurotransmitter drugs showed improvement

136. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
     January 01, 2012 - For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the four topics for which (1) preliminary phase III data for drugs and … Most research activity in this priority area is focusing on drugs and biologics for irritable bowel … Curr Opin Investig Drugs 2001 Apr;2(4):505-9. PMID: 11566007 43. Tappenden K, Edelman J.

137. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
     November 27, 2012 - , just as non- biologics for psoriasis are not considered a “class” of drugs either. … We have added the terms biologic and nonbiologic to our glossary with a listing of the drugs which … Suggest specifically mentioning the nonbiologic drugs. Thank you for this suggestion. … Are they naïve to both drugs (mtx, adalimumab, etanercept?) Thank you for this suggestion. … More information about each of the drugs and phototherapy would be helpful.

138. rheumatoid-arthritis-medicine-update-protocol-170515 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-update_research-protocol.pdf
     May 15, 2017 - Newly approved drugs and those under review by the FDA are described in Section B (see Table 1) above … Few data are available on efficacy for these drugs; even less is known about how their effectiveness … and harms compared with that of existing drugs. … What has Changed New drugs: Additional clinical trials of three biosimilar drugs and a tsDMARD (an … Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease.

139. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
     September 01, 2011 - A few years ago, these drugs were all off label for autism, depression, augmentation of depression, … Actually, we refrained from doing pooled analyses across, drugs in response to reviewers comments … So, we think the report is suitably restrained on drawing conclusions across drugs. … As these drugs are approved for use in MDD, rationale for inclusion of the data in the report should … The drugs are still included in the chart for comparative purposes.

140. Introduction (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
     February 01, 2009 - Annual age-specific utilization of DMARDs, glucocorticoids, non-steroidal anti- inflammatory drugs (NSAIDs … rheumatoid arthritis, disease modifying anti-rheumatic drugs, epidemiology Effective Health Care … 8 Introduction The treatment of rheumatoid arthritis (RA) with disease modifying anti-rheumatic drugs … Interestingly, about 10% of patients were not using any study drugs on the index dates. … The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis